Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/evidence-based-strategies-for-treatment-of-allergic-rhinitis-vQ0BEsoDWw
References (20)
-
G. Petersson, S. Djueborg, R. Ingestad (1986)
Clinical History, Skin Prick Test and RAST in the Diagnosis of Birch and Timothy PollinosisAllergy, 41
-
M. Karaayvaz, F. Erel, Z. Caliskaner, N. Ozangüç (1999)
Systemic reactions due to allergen immunotherapy.Journal of investigational allergology & clinical immunology, 9 1
-
P. Ratner, W. Howland, Raiqua Arastu, E. Philpot, Kristofer Klein, Charlotte Baidoo, M. Faris, K. Rickard (2003)
Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 90 5
-
W. Lumry (1999)
A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.The Journal of allergy and clinical immunology, 104 4 Pt 1
-
C. Laforce, R. Dockhorn, B. Prenner, Theodore Chu, Michael Kraemer, M. Widlitz, T. D'Eletto, J. Freitag (1996)
Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 76 2
-
J. Portnoy, S. Simon (2003)
Is 3-mm less drowsiness important?Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 91 4
-
D Sackett, S Straus, W Richardson (2000)
Evidence-Based Medicine: How to Practice and Teach EBM -
W. Berger, M. White (2003)
Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 91 2
-
S Bent, D Friedland (1998)
Evidence-Based Medicine: A Framework for Clinical Practice. -
W. Fokkens, E. Cserháti, J. Santos, F. Praça, Marinus Zanten, Alexander Schade, G. Simon (2002)
Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 89 3
-
U. Wahn, E. Meltzer, A. Finn, M. Kowalski, P. Decosta, G. Hedlin, P. Scheinmann, C. Bachert, J. Pinto, C. Baena-Cagnani, P. Potter, F. Simons, E. Ruuth (2003)
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.The Journal of allergy and clinical immunology, 111 4
-
H. Nelson, J. Oppenheimer, A. Buchmeier, T. Kordash, L. Freshwater (1996)
An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass.The Journal of allergy and clinical immunology, 97 6
-
P. Chervinsky, T. Casale, R. Townley, I. Tripathy, S. Hedgecock, A. Fowler-Taylor, Henry Shen, H. Fox (2003)
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 91 2
-
R. Sly (2002)
Epidemiology of allergic rhinitisClinical Reviews in Allergy & Immunology, 22
-
J. Day, M. Briscoe, M. Widlitz (1998)
Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.The Journal of allergy and clinical immunology, 101 5
-
P. Williams, S. Ahlstedt, J. Barnes, L. Söderström, J. Portnoy (2003)
Are our impressions of allergy test performances correct?Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 91 1
-
Zev Munk, C. Laforce, J. Furst, B. Simpson, Gary Feiss, Joseph Smith (1996)
Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 77 4
-
K. Gendo, E. Larson (2004)
Evidence-Based Diagnostic Strategies for Evaluating Suspected Allergic RhinitisAnnals of Internal Medicine, 140
-
S. Walker, G. Pajno, M. Lima, Duncan Wilson, S. Durham (2001)
Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.The Journal of allergy and clinical immunology, 107 1
-
M Hepner, D Ownby, H MacKechnic (1987)
The safety of immunotherapy: a prospective studyJ Allergy Clin Immunol, 97
- Publisher
- Springer Journals
- Copyright
- Copyright © 2004 by Current Science Inc
- Subject
- Medicine & Public Health; Allergology; Pneumology/Respiratory System; Otorhinolaryngology; Infectious Diseases
- ISSN
- 1529-7322
- eISSN
- 1534-6315
- DOI
- 10.1007/s11882-004-0009-1
- Publisher site
- See Article on Publisher Site
Abstract
In this review, an evidence-based medicine approach to diagnosis and treatment for allergic rhinitis is reviewed. We performed a search of the medical literature for randomized, placebo-controlled trials of nonsedating antihistamines, intranasal corticosteroids, montelukast, azelastine, allergen immunotherapy, and anti-IgE. The mean numbers needed to treat were: nonsedating antihistamines—15.2; nasal corticosteroids—4.4; montelukast—14.3; azelastine—5.0; allergen immunotherapy—4.6; and anti-IgE—12.4. Treatment thresholds for use were: antihistamines—23%; nasal corticosteroids —8%; azelastine—16%; montelukast—8%; anti-IgE—50%; and immunotherapy—25%. When used appropriately, this information could become very useful for clinicians, particularly if cost, convenience, and other indirect factors can be included.
Journal
Current Allergy and Asthma Reports – Springer Journals
Published: May 27, 2004